4.7 Article

Comparative Evaluation of the Translocator Protein Radioligands 11C-DPA-713, 18F-DPA-714, and 11C-PK11195 in a Rat Model of Acute Neuroinflammation

期刊

JOURNAL OF NUCLEAR MEDICINE
卷 50, 期 3, 页码 468-476

出版社

SOC NUCLEAR MEDICINE INC
DOI: 10.2967/jnumed.108.058669

关键词

TSPO (18-kDa); PBR; peripheral benzodiazepine receptor; PET; neuroinflammation; (IF)-I-18-DPA-714; C-11-DPA-713; C-11-PK11195

资金

  1. EC-FP6 [LSBC-CT-2004-503569, LSHB-CT-2005-512146]
  2. FWO fellowship from Belgium

向作者/读者索取更多资源

Overexpression of the translocator protein, TSPO (18 kDa), formerly known as the peripheral benzodiazepine receptor, is a hallmark of activation of cells of monocytic lineage (microglia and macrophages) during neuroinflammation. Radiolabeling of TSPO ligands enables the detection of neuroinflammatory lesions by PET. Two new radioligands, C-11-labeled N,N-diethyl-2-[2-(4-methoxyphenyl)-5,7-dimethylpyrazolo[1,5-alpha]pyrimidin-3-yl] acetamide (DPA-713) and F-18-labeled N,N-diethyl-2-(2-(4-(2-fluoroethoxy)phenyl)-5,7-dimethylpyrazolo[1,5-alpha]pyrimidin-3-yl) acetamide (DPA-714), both belonging to the pyrazolopyrimidine class, were compared in vivo and in vitro using a rodent model of neuroinflammation. Methods: C-11-DPA-713 and F-18-DPA-714, as well as the classic radioligand C-11-labeled (R)-N-methyl-N-(1 -methylpropyl)-1-(2-chlorophenyl)isoquinoline-3-carboxamide (PK11195), were used in the same rat model, in which intrastriatal injection of (R,S)-alpha-amino-3-hydroxy-5-methyl-4-isoxazolopropionique gave rise to a strong neuroinflammatory response. Comparative endpoints included in vitro autoradiography and in vivo imaging on a dedicated small-animal PET scanner under identical conditions. Results: C-11-DPA-713 and F-18-DPA-714 could specifically localize the neuroinflammatory site with a similar signal-to-noise ratio in vitro. In vivo, F-18-DPA-714 performed better than C-11-DPA-713 and C-11-PK11195, with the highest ratio of ipsilateral to contralateral uptake and the highest binding potential. Conclusion: F-18-DPA-714 appears to be an attractive alternative to C-11-PK11195 because of its increased bioavailability in brain tissue and its reduced nonspecific binding. Moreover, its labeling with F-18, the preferred PET isotope for radiopharmaceutical chemistry, favors its dissemination and wide clinical use. F-18-DPA-714 will be further evaluated in longitudinal studies of neuroinflammatory conditions such as are encountered in stroke or neurodegenerative diseases.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据